Mentice
21.2
SEK
+0.47 %
MNTC
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
+0.47%
-28.14%
-24.56%
-35.95%
-55.56%
-51.82%
-79.42%
-77.8%
-68.64%
investor.mentice.com
Mentice is a medical technology company. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for educational use in hospitals and institutes. The largest operations are established in North America and Europe. In addition to the main business, the company also offers leasing, support, and technical service. The head office is located in Gothenburg.
Revenue
273.61M
EBIT %
-0.25 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
MNTC
Daily low / high price
21.1 / 21.6
SEK
Market cap
542.06M SEK
Turnover
103.18K SEK
Volume
4.8K
Financial calendar
Annual report
2025-02-13
General meeting
2025-05-22
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Karin Howell-Bidermann | 34.0 % | 34.0 % |
| Bure Equity AB | 14.7 % | 14.7 % |
| Fjärde AP-fonden | 7.7 % | 7.7 % |
| Gulf Offshore Limited | 6.2 % | 6.2 % |
| Medical Simulation Corporation | 4.8 % | 4.8 % |
| Handelsbanken Fonder | 3.1 % | 3.1 % |
| Berenberg Funds | 3.1 % | 3.1 % |
| Göran Malmberg | 2.8 % | 2.8 % |
| Andra AP-fonden | 1.8 % | 1.8 % |
| Handelsbanken Liv Försäkring AB | 1.4 % | 1.4 % |
ShowingAll content types
Penser Access & Future by Carnegie: Mentice: Fortsatt hög volatilitet mellan kvartalen - Q3 review
Penser Access & Future by Carnegie: Mentice: Interview - Q3 interim report webcast
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools